alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                               5
<LEGEND>
                  This schedule contains summary financial information extracted
                  from Wasatch Pharmaceutical,  Inc. December 31, 1996 financial
                  statements  and is  qualified  in its entirety by reference to
                  such financial statements.
</LEGEND>

<CIK>                                            0000853465
<NAME>                                           Wasatch Pharmaceutical, Inc.

       

<S>                                              <C>
<PERIOD-TYPE>                                    YEAR
<FISCAL-YEAR-END>                                DEC-31-1996
<PERIOD-END>                                     DEC-31-1996
<CASH>                                                        0
<SECURITIES>                                                  0
<RECEIVABLES>                                                 0
<ALLOWANCES>                                                  0
<INVENTORY>                                                   0
<CURRENT-ASSETS>                                              0
<PP&E>                                                        0
<DEPRECIATION>                                                0
<TOTAL-ASSETS>                                                0
<CURRENT-LIABILITIES>                                         0
<BONDS>                                                       0
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                                   0
<COMMON>                                                      1,000
<OTHER-SE>                                                   (1,000)
<TOTAL-LIABILITY-AND-EQUITY>                                  0
<SALES>                                                       0
<TOTAL-REVENUES>                                              0
<CGS>                                                         0
<TOTAL-COSTS>                                                 0
<OTHER-EXPENSES>                                              0
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                            0
<INCOME-PRETAX>                                               0
<INCOME-TAX>                                                  0
<INCOME-CONTINUING>                                           0
<DISCONTINUED>                                                0
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                                  0
<EPS-PRIMARY>                                                 .00
<EPS-DILUTED>                                                 .00
        


</TABLE>
**EXHIBIT 32.1**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Inconnection with the Form 10-Q of Redpoint Bio Corporation (the “Company”)for the period ended June 30, 2010 as filed with the Securities andExchange Commission on the date hereof (the “Report”), the undersigned, F.Raymond Salemme, President and Chief Executive Officer of the Company, herebycertifies, pursuant to 18 U.S.C. Section 1350, that:

 

(1) TheReport fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934; and

 

(2) Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 
| Dated:  August 13, 2010 | /s/  F. Raymond Salemme                |
|------------------------------|----------------------------------------|
|                         | F.  Raymond Salemme                    |
|                         | President  and Chief Executive Officer |
|                         | (Principal  Executive Officer)         |

 

----

* A signed original of this written statementrequired by Section 906 has been provided to Redpoint Bio Corporation andwill be retained by Redpoint Bio Corporation and furnished to the Securitiesand Exchange Commission or its staff upon request.

 

----
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 16-11032

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

MARCOS DANIEL CHAIREZ,

Defendant-Appellant

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 5:15-CR-96-1

Before JOLLY, PRADO, and SOUTHWICK, Circuit Judges.

PER CURIAM:*

The Federal Public Defender appointed to represent Marcos Daniel 

Chairez has moved for leave to withdraw and has filed a brief in accordance 

with Anders v. California, 386 U.S. 738 (1967), and United States v. Flores, 632

F.3d 229 (5th Cir. 2011). Chairez has not filed a response. We have reviewed 

counsel’s brief and the relevant portions of the record reflected therein. We 

concur with counsel’s assessment that the appeal presents no nonfrivolous 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

February 21, 2017

Lyle W. Cayce

Clerk

 Case: 16-11032 Document: 00513882759 Page: 1 Date Filed: 02/21/2017
No. 16-11032

2

issue for appellate review. Accordingly, counsel’s motion for leave to withdraw 

is GRANTED, counsel is excused from further responsibilities herein, and the 

APPEAL IS DISMISSED. See 5TH CIR. R. 42.2.

 Case: 16-11032 Document: 00513882759 Page: 2 Date Filed: 02/21/2017
[Federal Register Volume 77, Number 39 (Tuesday, February 28, 2012)]
[Notices]
[Page 12103]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-4655]


-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 7807]


Culturally Significant Objects Imported for Exhibition 
Determinations: ``Colorful Realm: Japanese Bird-and-Flower Paintings by 
It[omacr] Jakuch[umacr] (1716-1800)''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, and Delegation of Authority No. 
236-3 of August 28, 2000 (and, as appropriate, Delegation of Authority 
No. 257 of April 15, 2003), I hereby determine that the objects to be 
included in the exhibition ``Colorful Realm: Japanese Bird-and-Flower 
Paintings by It[omacr] Jakuch[umacr] (1716-1800),'' imported from 
abroad for temporary exhibition within the United States, are of 
cultural significance. The objects are imported pursuant to loan 
agreements with the foreign owners or custodians. I also determine that 
the exhibition or display of the exhibit objects at the National 
Gallery of Art, Washington, DC, from on or about March 30, 2012, until 
on or about April 29, 2012, and at possible additional exhibitions or 
venues yet to be determined, is in the national interest. I have 
ordered that Public Notice of these Determinations be published in the 
Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Paul W. Manning, Attorney-Adviser, 
Office of the Legal Adviser, U.S. Department of State (telephone: 202-
632-6469). The mailing address is U.S. Department of State, SA-5, L/PD, 
Fifth Floor (Suite 5H03), Washington, DC 20522-0505.

    Dated: February 22, 2012.
J. Adam Ereli,
Principal Deputy Assistant Secretary, Bureau of Educational and 
Cultural Affairs, Department of State.
[FR Doc. 2012-4655 Filed 2-27-12; 8:45 am]
BILLING CODE 4710-05-P
**Exhibit
      32.1**








Tronox
      Incorporated


123
      Robert S. Kerr Avenue


Oklahoma
      City, Oklahoma 73102








**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER**


**REGARDING
      PERIODIC REPORT CONTAINING**


**FINANCIAL
      STATEMENTS**








I,
      Thomas
      W. Adams, the Chief Executive Officer of Tronox Incorporated, in compliance
      with
      18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, hereby certify in connection with the registrant’s report on Form
      10-Q for the period that ended September 30, 2006 as filed with the Securities
      and Exchange Commission (the “Report”) that:





·
            the
                Report fully complies with the requirements of Section 13(a) of the
                Securities Exchange Act of 1934;
                and





·
            information
                contained in the Report fairly presents, in all material respects,
                the
                financial condition and results of operations of the
                Issuer.











/s/
      Thomas W. Adams





Thomas
      W.
      Adams


Chief
      Executive Officer


November
      14, 2006
Electronically Filed

Intermediate Court of Appeals

CAAP-12-0000962

28-JAN-2014

11:09 AM
**EXHIBIT 32**

**Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Professional Veterinary Products, Ltd. Form 10-K (the “Report”) for the year ended July 31, 2008, each of the undersigned hereby certifies that:

1.         The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2.         The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Professional Veterinary Products, Ltd.

A signed original of this written statement required by Section 906 has been provided to Professional Veterinary Products, Ltd. and will be retained by Professional Veterinary Products, Ltd. and furnished to the SEC or its staff upon request.

 

| /s/ Dr. Lionel L. Reilly | October 23, 2008                                                                                                                                                                                        |
|-------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Dr. Lionel L. Reilly     |  
President/Chief Executive Officer

 
 

/s/ Neal B. Soderquist

October 23, 2008

Neal B. Soderquist

 
Chief Financial Officer and Vice President

 
 

 

  |
Mosquito pesticide use in Florida
Dwinell, Steve

to:

Jack Faulk

09/18/2009 02:37 PM

Cc:
"Coram, Phil", "Caton, William", "Dennis Howard"

Show Details

On the conference call yesterday someone asked if ther e were data on what pesticide products would be used in mosquito control. In Florida, regulat ed districts report pestic ide use on a monthly basis. These are compiled by the Department and posted as annu al reports on our website - http://www.flaes.org/pdf/FY07

- 08_Annual_Pesticide_Activity_Report.pdf

Below is an example of what is collected -

http://www.flaes.org/pdf/FY07

- 08_Annual_Pesticide_Activity_Report.pdf

Please let me know if you have any qu estions regarding this data. Thanks.

Steven E. Dwinell

A ssistant Directo r Division of Agricultural Environmental Services Florida Department of Agriculture and Consumer Services

3125 Conner Boulevard

Tallahassee Florida 32399

850-488-7447

850-488-2164 Fax

Please note: Florida has a very broad public records law. Most written communications to or from state officials regarding state business are public records availabl e to the public and media upon request. Your e-mail communications may therefore be subject to public disclosure. Page 1 of 1

5/11/2010 file://C:\Documents and Settin g s\ j faulk\Local Settin g s\Tem p \notesFCBCEE\~web6023.htm
**EXHIBIT 32****Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,in connection with the filing of the Professional Veterinary Products, Ltd. Form 10-K/A (the“Report”) for the year ended July 31, 2004, each of the undersigned hereby certifies that:1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934, as amended, and2. The information contained in the Report fairly presents, in all material respects, the financialcondition and results of operations of Professional Veterinary Products, Ltd.     A signed original of this written statement required by Section 906 has been provided toProfessional Veterinary Products, Ltd. and will be retained by Professional Veterinary Products,Ltd. and furnished to the SEC or its staff upon request.   /s/ Lionel L. Reilly July 28, 2005Dr. Lionel L. Reilly  President/Chief Executive Officer     /s/ Neal B. Soderquist July 28, 2005Neal B. Soderquist
---

Exhibit 13


2 0 1 2   F O R M - 2 0 F    E X H I B I T - 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form-20F for fiscal year ended June 30, 2012of Continental Energy Corporation, a British Columbia, Canada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, Richard L. McAdoo, Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1.

   The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and2.

   The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 9, 2012 <Signed> __________________ Richard L. McAdoo CEO  2 0 1 2   F O R M - 2 0 F    E X H I B I T - 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form-20F for fiscal year ended June 30, 2012of Continental Energy Corporation, a British Columbia, Canada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, Robert V. Rudman, Chief Financial Officer of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1.

   The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and2.

   The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 9, 2012 <Signed> __________________ Robert V. Rudman CFO A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, orotherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Continental Energy Corporation and will be retained by Continental Energy Corporation and furnished to the Securities and Exchange Commission or its staff upon request.


---
<TABLE> <S> <C>

<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           4,582
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                          24,437
<INVESTMENTS-MARKET>                            24,437
<LOANS>                                         91,795
<ALLOWANCE>                                        800
<TOTAL-ASSETS>                                 128,478
<DEPOSITS>                                     103,311
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                             12,414
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           309
<OTHER-SE>                                      12,444
<TOTAL-LIABILITIES-AND-EQUITY>                 128,478
<INTEREST-LOAN>                                  7,322
<INTEREST-INVEST>                                1,425
<INTEREST-OTHER>                                    57
<INTEREST-TOTAL>                                 8,804
<INTEREST-DEPOSIT>                               3,742
<INTEREST-EXPENSE>                               4,325
<INTEREST-INCOME-NET>                            4,479
<LOAN-LOSSES>                                      195
<SECURITIES-GAINS>                                   6
<EXPENSE-OTHER>                                  3,011
<INCOME-PRETAX>                                  1,862
<INCOME-PRE-EXTRAORDINARY>                       1,466
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,466
<EPS-BASIC>                                       2.96
<EPS-DILUTED>                                     2.96
<YIELD-ACTUAL>                                    3.93
<LOANS-NON>                                          0
<LOANS-PAST>                                       168
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   580
<CHARGE-OFFS>                                       47
<RECOVERIES>                                        72
<ALLOWANCE-CLOSE>                                  800
<ALLOWANCE-DOMESTIC>                               800
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
Exhibit
32.2


Certification
of Principal Financial Officer


Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002




In
connection with the Quarterly Report on Form 10-Q for the quarter ended March
31, 2010 (the “Report”) of United States Oil Fund, LP (the “Registrant”), as
filed with the Securities and Exchange Commission on the date hereof, I, Howard
Mah, the Chief Financial Officer of United States Commodity Funds LLC, General
Partner of the Registrant, hereby certify, to the best of my knowledge,
that:




(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.







Date:
      May 10, 2010
              By:
              /s/
      Howard MahName:
                Title:
              Howard
      Mah
                Chief
      Financial Officer
                United
      States Commodity Funds LLC,
                General
      Partner of United States Oil Fund,
LP
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# AGENCY:

National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services.

# ACTION:

Notice.

# SUMMARY:

NIOSH gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees from the Ventron Corporation site in Beverly, Massachusetts, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows:

*Facility:*                         Ventron Corporation.                    

*Location:*                         Beverly, Massachusetts.                    

*Job Titles and/or Job Duties:*                         All Atomic Weapons Employees.                    

*Period of Employment:*                         January 1, 1942 through December 31, 1948.                    

      ( print page 12594)    

# FOR FURTHER INFORMATION CONTACT:

                        Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 4676 Columbia Parkway, MS C-46, Cincinnati, OH 45226, Telephone 877-222-7570. Information requests can also be submitted by email to                         *DCAS@CDC.GOV.*

John Howard,

Director, National Institute for Occupational Safety and Health.

[FR Doc. 2012-4953 Filed 2-29-12; 8:45 am]

BILLING CODE 4163-19-P